- Pediatric radiology leaders launch AI brain tumor dataset
- Inside SCA Health’s clinical nursing ladder — and how it helped cut turnover by 7%
- What ASCs are getting wrong about OR delays — and how to fix it
- 1 behavioral health leader’s playbook for staff retention and safety
- Centene executive to join Froedtert ThedaCare as chief nurse
- Behavioral health ED visits projected to rise by 1 million
- UPMC provides free RN-BSN degree to its nurses
- Physicians aren’t buying payers’ prior auth pledge: 5 survey notes
- 5 dental AI updates in 1 month
- 3 lawsuit settlements in dentistry
- Financial pressures shutter Iowa dental clinics: 4 notes
- 4 cities where systems are winning new grads from tech, finance
- Medline launches predictive supply chain platform and 5 more updates to know
- Independent autism research committee adds 7 members
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- 10 notes on the widening DSO performance gap
- Health systems are betting on retail partnerships
- CDC-linked autism researcher arraigned on fraud charges
- Nearly 1 in 3 boys under 14 discussed suicide in crisis conversations: Report
- How anesthesia became a financial liability for ASCs
- 4 pressures converging on pharmacy
- Ascension Texas hospital taps new assistant CFO
- 82% of physicians are now employed: 6 notes
- Atlanta-area medical office portfolio sold in leaseback deal
- 23 revenue cycle executive moves in 2026
- FDA warns blood cancer risk tied to oncology drug
- New warning sign for sudden cardiac death found: Study
- NAPA partners with New York hospital
- Remarks at the MFA Legal & Compliance 2026 Conference
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- NorthStar inks 3 ASC partnerships
- CMS pauses hospice, home health Medicare enrollments in fraud crackdown
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
- Health systems are exploring AI-powered opportunistic screening. New CMS reimbursement could unlock a business case for it
- Most mental health practitioners satisfied with work, financially stable, SimplePractice finds
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Haleon tackles sports injuries with latest soccer play
- Eating Out Linked To Obesity Risk Worldwide
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
- Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
- California to award $111M for behavioral health supportive housing
- 6 new psychiatric residency programs to know
- USOSM adds New York practice
- NAMI partners on health crisis preparation hub
- CMS proposes nationwide joint replacement payment model
- Oklahoma enacts law expanding access to dental care
- Where dentists are leaving value behind in practice sales
- Why dental practices are closing in 2026
- Texas dental school to launch master’s program with orthodontic specialty
- Qualitas Dental Partners makes investments into 7 practices
- Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
- 988 calls are rising — what’s behind the surge?
- Providence hospital to lay off 40 workers amid behavioral health staffing overhaul
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- University of California, union near May 14 strike deadline with no deal in hand
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Optum Rx unveils new transparent PBM model
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- ACA exchanges take spotlight in Q1
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- The broken pipeline of mental healthcare for LGBTQ teenagers
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- Is your hospital ready for a prolonged IT outage? Joint Commission, AHA's new resiliency program will let you know
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- Watch: 8 Health Insurance Terms You Should Know
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- The Make America Healthy Again Movement Comes for Hospital Food
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Skil-Care launches specialized healthcare product innovation program
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- Remarks at the Special Competitive Studies Project AI+ Expo
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Remarks at the 13th Annual Conference on Financial Market Regulation
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
I am so old I can remember when being anti-vaxx was the worst offense an American citizen could commit against the U.S. Government. I am so old I remember the U.S. Armed Forces expelling service men and women who refused to be vaccinated.
Guess who ran a huge anti-vaxx campaign during the COVID pandemic? None other than the U.S. Government's Department of Defense!
The Reuters exposé is too long to reproduce in full, but here is the lede:
https://www.reuters.com/investigates/special-report/usa-covid-propaganda/
Pentagon ran secret anti-vax campaign to undermine China during pandemicThe U.S. military launched a clandestine program amid the COVID crisis to discredit China’s Sinovac inoculation – payback for Beijing’s efforts to blame Washington for the pandemic. One target: the Filipino public. Health experts say the gambit was indefensible and put innocent lives at risk.
By Chris Bing and Joel Schectman - June 14, 2024
At the height of the COVID-19 pandemic, the U.S. military launched a secret campaign to counter what it perceived as China’s growing influence in the Philippines, a nation hit especially hard by the deadly virus.
The clandestine operation has not been previously reported. It aimed to sow doubt about the safety and efficacy of vaccines and other life-saving aid that was being supplied by China, a Reuters investigation found. Through phony internet accounts meant to impersonate Filipinos, the military’s propaganda efforts morphed into an anti-vax campaign. Social media posts decried the quality of face masks, test kits and the first vaccine that would become available in the Philippines – China’s Sinovac inoculation.
Reuters identified at least 300 accounts on X, formerly Twitter, that matched descriptions shared by former U.S. military officials familiar with the Philippines operation. Almost all were created in the summer of 2020 and centered on the slogan #Chinaangvirus – Tagalog for China is the virus.
This post, identified by Reuters, matched the messaging, timeframe and design of the U.S. military’s anti-vax propaganda campaign in the Philippines, former and current military officials say. Social media platform X also identified the account as fake and removed it.
TRANSLATION FROM TAGALOG
#ChinaIsTheVirus
Do you want that? COVID came from China and vaccines came from China
(Beneath the message is a picture of then-Philippines President Rodrigo Duterte saying: “China! Prioritize us first please. I’ll give you more islands, POGO and black sand.” POGO refers to Philippine Offshore Gaming Operators, online gambling companies that boomed during Duterte’s administration. Black sand refers to a type of mining.)
“COVID came from China and the VACCINE also came from China, don’t trust China!” one typical tweet from July 2020 read in Tagalog. The words were next to a photo of a syringe beside a Chinese flag and a soaring chart of infections. Another post read: “From China – PPE, Face Mask, Vaccine: FAKE. But the Coronavirus is real.”
After Reuters asked X about the accounts, the social media company removed the profiles, determining they were part of a coordinated bot campaign based on activity patterns and internal data.
The U.S. military’s anti-vax effort began in the spring of 2020 and expanded beyond Southeast Asia before it was terminated in mid-2021, Reuters determined. Tailoring the propaganda campaign to local audiences across Central Asia and the Middle East, the Pentagon used a combination of fake social media accounts on multiple platforms to spread fear of China’s vaccines among Muslims at a time when the virus was killing tens of thousands of people each day. A key part of the strategy: amplify the disputed contention that, because vaccines sometimes contain pork gelatin, China’s shots could be considered forbidden under Islamic law.
The military program started under former President Donald Trump and continued months into Joe Biden’s presidency, Reuters found – even after alarmed social media executives warned the new administration that the Pentagon had been trafficking in COVID misinformation. The Biden White House issued an edict in spring 2021 banning the anti-vax effort, which also disparaged vaccines produced by other rivals, and the Pentagon initiated an internal review, Reuters found.
“I don’t think it’s defensible. I’m extremely dismayed, disappointed and disillusioned to hear that the U.S. government would do that.”
Daniel Lucey, infectious disease specialist at Dartmouth’s Geisel School of Medicine.
The U.S. military is prohibited from targeting Americans with propaganda, and Reuters found no evidence the Pentagon’s influence operation did so.Spokespeople for Trump and Biden did not respond to requests for comment about the clandestine program.
A senior Defense Department official acknowledged the U.S. military engaged in secret propaganda to disparage China’s vaccine in the developing world, but the official declined to provide details.
A Pentagon spokeswoman said the U.S. military “uses a variety of platforms, including social media, to counter those malign influence attacks aimed at the U.S., allies, and partners.” She also noted that China had started a “disinformation campaign to falsely blame the United States for the spread of COVID-19.”
In an email, the Chinese Ministry of Foreign Affairs said that it has long maintained the U.S. government manipulates social media and spreads misinformation.
Manila’s embassy in Washington did not respond to Reuters inquiries, including whether it had been aware of the Pentagon operation. A spokesperson for the Philippines Department of Health, however, said the “findings by Reuters deserve to be investigated and heard by the appropriate authorities of the involved countries.” Some aide workers in the Philippines, when told of the U.S. military propaganda effort by Reuters, expressed outrage.
Briefed on the Pentagon’s secret anti-vax campaign by Reuters, some American public health experts also condemned the program, saying it put civilians in jeopardy for potential geopolitical gain. An operation meant to win hearts and minds endangered lives, they said.
“I don’t think it’s defensible,” said Daniel Lucey, an infectious disease specialist at Dartmouth’s Geisel School of Medicine. “I’m extremely dismayed, disappointed and disillusioned to hear that the U.S. government would do that,” said Lucey, a former military physician who assisted in the response to the 2001 anthrax attacks.
The effort to stoke fear about Chinese inoculations risked undermining overall public trust in government health initiatives, including U.S.-made vaccines that became available later, Lucey and others said. Although the Chinese vaccines were found to be less effective than the American-led shots by Pfizer and Moderna, all were approved by the World Health Organization. Sinovac did not respond to a Reuters request for comment.
Academic research published recently has shown that, when individuals develop skepticism toward a single vaccine, those doubts often lead to uncertainty about other inoculations. Lucey and other health experts say they saw such a scenario play out in Pakistan, where the Central Intelligence Agency used a fake hepatitis vaccination program in Abbottabad as cover to hunt for Osama bin Laden, the terrorist mastermind behind the attacks of September 11, 2001. Discovery of the ruse led to a backlash against an unrelated polio vaccination campaign, including attacks on healthcare workers, contributing to the reemergence of the deadly disease in the country.
“It should have been in our interest to get as much vaccine in people’s arms as possible,” said Greg Treverton, former chairman of the U.S. National Intelligence Council, which coordinates the analysis and strategy of Washington’s many spy agencies. What the Pentagon did, Treverton said, “crosses a line.”
Continued at the hyperlink, above.....
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















